Last reviewed · How we verify
NCT05230914
A Randomized Trial of Imaging Selection Modalities for Stroke Thrombectomy (NO-SELECT)
NA trial testing Simplified imaging strategy in Stroke, Ischemic in 1,846 participants. Currently enrolling.
30 June 2027
Quick facts
| Lead sponsor | Xinqiao Hospital of Chongqing |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 1,846 |
| Start date | 12 December 2024 |
| Primary completion | 30 June 2027 |
| Estimated completion | 31 October 2027 |
| Sites | 8 locations across China |
Drugs / interventions tested
- Simplified imaging strategy
- Standard imaging strategy
Conditions studied
- Stroke, Ischemic — all drugs for Stroke, Ischemic →
- Stroke, Acute — all drugs for Stroke, Acute →
Sponsor
Xinqiao Hospital of Chongqing
Who can join
18 and older, any sex, with Stroke, Ischemic or Stroke, Acute. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several studies suggest that advanced multi-modal imaging with CTP should be used to screen late time window stroke patients for thrombectomy. However, NCCT is more accessible when comparing with CTP. It is unclear whether the NCCT-based ASPECTS can be used as an imaging criterion to screen patients for thrombectomy. The newly published MR CLEAN-LATE and TENSION trials used NCCT or CTA, but still relied on ASPECTS scores to evaluate and select patients for endovascular therapy. However, different trials have different time windows. The aim of this trial was to assess the clinical outcomes of stroke patients with anterior large vessel occlusion who selected by simple imaging (NCCT) comparing via standard imaging screening strategy (CTP/MRI). The hypothesis is that simple imaging is non-inferior to standard imaging selection strategy in terms of achieving favorable outcomes.
Publications & conference data
6 peer-reviewed publications reference this trial (live from Europe PMC):
-
Neuroimaging of Acute Ischemic Stroke: Multimodal Imaging Approach for Acute Endovascular Therapy.
Abdalkader M, Siegler JE, Lee JS, Yaghi S, et al · · 2023 · cited 50× · PMID 36746380 · DOI 10.5853/jos.2022.03286 -
Mechanical Thrombectomy in the Late Presentation of Anterior Circulation Large Vessel Occlusion Stroke: A Guideline From the Society of Vascular and Interventional Neurology Guidelines and Practice Standards Committee.
Nguyen TN, Castonguay AC, Siegler JE, Nagel S, et al · · 2023 · cited 31× · PMID 39380893 · DOI 10.1161/svin.122.000512 -
Perfusion vs non-perfusion computed tomography imaging in the late window of emergent large vessel ischemic stroke: A systematic review and meta-analysis.
Diestro JDB, Omar AT, Zhang YQ, Kishibe T, et al · · 2024 · cited 9× · PMID 38166040 · DOI 10.1371/journal.pone.0294127 -
Late Window Imaging Selection for Endovascular Therapy of Large Vessel Occlusion Stroke: An International Survey.
Nguyen TN, Klein P, Berberich A, Nagel S, et al · · 2023 · cited 2× · PMID 41585765 · DOI 10.1161/svin.122.000595 -
Clinical Uncertainty in Large Vessel Occlusion ischemic stroke (CULVO): Does automated perfusion scanning make a difference? Protocol of an intrarater and interrater agreement study.
Diestro JDB, Fahed R, Benomar A, Omar AT, et al · · 2024 · cited 2× · PMID 38289912 · DOI 10.1371/journal.pone.0297520 -
Selection by Noncontrast Computed Tomography With or Without Computed Tomography Angiography Versus Computed Tomography Perfusion for Endovascular Therapy in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Zhang Y, Zhao Y, Deng B, Wu S, et al · · 2025 · cited 1× · PMID 40497499 · DOI 10.1161/jaha.124.038173
Verify or expand the search:
- PubMed search for NCT05230914
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke, Ischemic
Currently open trials in the same condition.
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT06658197 — Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke · Phase 3 · recruiting
- NCT07282041 — Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis · Phase 2, PHASE3 · recruiting
- NCT07135089 — Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban · Phase 3 · recruiting
- NCT07047014 — Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ische · Phase 3 · recruiting
Other Xinqiao Hospital of Chongqing trials
Trials by the same sponsor.
- NCT07347626 — Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis · Phase 3 · not yet recruiting
- NCT07349836 — Application of mRNA Immunotherapy Technology in EB Virus Related Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07362758 — Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07349849 — Exploratory Study on mRNA Therapeutic Drug Targeting CD19 for the Treatment of Hematologic Malignancies · EARLY_PHASE1 · recruiting
- NCT06987305 — Intravenous rhTNK-tPA Before Stroke Thrombectomy in the Extended Time Window · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05230914 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xinqiao Hospital of Chongqing
- Last refreshed: 26 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05230914.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing